Clinical Trial Update: Study on the Pathogenesis of Retinal Vascular Diseases Based on Body Fluid Metabolomics

View source ↗

Summary

This clinical trial investigates the pathogenesis of retinal vascular diseases using body fluid metabolomics. Sponsor: Zhongnan Hospital; status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinopathy

Snippet

Sponsor: Zhongnan Hospital | Conditions: Metabolomics; Retinopathy; Etiology | Status: UNKNOWN